PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | C0020456|hyperglycemia |
| Sentences | 9 |
| PubMedID- 26099223 | Advanced glycation end products (ages) are recognized as one of the important contributors to the pathogenesis of atherosclerosis in hyperglycemia [50]. |
| PubMedID- 21450068 | Several studies have attempted to find the link between hyperglycemia and development of coronary atherosclerosis [72,73]. |
| PubMedID- 22649373 | The primary mediator in atherosclerosis for patients with t1d is hyperglycemia (kavey et al., 2006). |
| PubMedID- 24899904 | In a recent publication by dcct, cimt has been established as a marker for atherosclerosis when associated with hyperglycemia [48]. |
| PubMedID- 24809394 | The key pathological mechanism underlying these conditions is atherosclerosis, resulting from hyperglycemia, chronic inflammation, and injury to the arterial wall [15]. |
| PubMedID- 20005514 | Aims: isolated hyperglycemia is associated with atherosclerosis in individuals with type 2 diabetes, but the relationship between postchallenge glucose excursion and atherosclerosis is less clear. |
| PubMedID- 23440913 | [29] furthermore, it is suggested that hypoxia under hyperglycemia leads to diabetic arteriosclerosis and calcification. |
| PubMedID- 24159000 | Diabetic cardiomyopathy is directly related to hyperglycemia, independent of hypertension or coronary atherosclerosis (43), and hyperglycemia is currently believed to promote production of reactive oxygen species, advanced glycation end products, and metabolic perturbations that result in increased glucose toxicity and myocardial injury and apoptosis (21,44). |
| PubMedID- 22185588 | Diabetes is now generally considered being one of the major risk factors of atherosclerosis, with the hyperglycemia as an underlying contributing factor [22]. |
Page: 1